Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Innoviva, Inc. - Common Stock (NQ:INVA)

20.91 -0.14 (-0.69%)
Delayed Quote Updated: 2:35 PM EDT, Oct 8, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Innoviva, Inc. - Common Stock

< Previous 1 2 3 4 Next >
Innoviva (NASDAQ:INVA) Fits the Affordable Growth Mold ↗
Via Chartmill
Innoviva (NASDAQ:INVA): An Undervalued Value Stock Backed by Strong Cash Flow ↗
Via Chartmill
Innoviva (INVA): Affordable Growth Stock at a Reasonable Valuation ↗
Via Chartmill
Innoviva Inc (NASDAQ:INVA): A Decent Value Play with Strong Fundamentals ↗
Via Chartmill
INNOVIVA INC (NASDAQ:INVA): A Strong Growth Stock Poised for a Technical Breakout ↗
Via Chartmill
Innoviva Inc (NASDAQ:INVA): A GARP Standout with 470% EPS Growth and a P/E of Just 6.05 ↗
Via Chartmill
News headline image
Innoviva Stock Is Up Just 10% This Past Year. Here's Why a Fund Bought $2.5 Million More ↗
Innoviva develops respiratory pharmaceuticals through strategic partnerships and royalty agreements in the global healthcare market. 
Via The Motley Fool
Topics Regulatory Compliance
INNOVIVA INC (NASDAQ:INVA) Scores as a Value Stock with Strong Fundamentals ↗
Via Chartmill
Innoviva Inc (NASDAQ:INVA) Screened as a Top Value Stock with Strong Fundamentals ↗
Via Chartmill
INNOVIVA INC (NASDAQ:INVA) Emerges as a High-Growth Momentum Pick Using Minervini's Trend Template ↗
Via Chartmill
Innoviva Inc (NASDAQ:INVA) Presents a Compelling Value Investment Case ↗
Via Chartmill
News headline image
Beyond The Numbers: 5 Analysts Discuss Innoviva Stock ↗
 
Via Benzinga
News headline image
3 Bargain-Cheap Small Caps Worth a Second Look ↗
Via MarketBeat
News headline image
Biohaven Stock Down 70% but One Fund's New $6 Million Bet Signals Turnaround Potential ↗
This clinical-stage biotech focuses on developing therapies for neurological and immunoscience disorders. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Biotech Is Heating Up—These 2 Red-Hot Stocks Stand Out ↗
Via MarketBeat
News headline image
Get insights into the top gainers and losers of Tuesday's after-hours session. ↗
Let's have a look at what is happening on the US markets after the closing bell on Tuesday. Below you can find the top gainers and losers in today's after hours session. 
Via Chartmill
News headline image
Stay updated with the stocks that are on the move in today's pre-market session. ↗
The US market session of Thursday has yet to be opened, let's have a look at the top gainers and losers in the pre-market session today. 
Via Chartmill
News headline image
Value Investing Case Study: INNOVIVA INC (NASDAQ:INVA) ↗
Discover Innoviva (INVA), a potential value stock with strong fundamentals. Its attractive valuation, healthy balance sheet, and solid profitability suggest it trades below intrinsic worth. 
Via Chartmill
News headline image
Innoviva Inc (NASDAQ:INVA): A Prime Candidate for Value Investors Seeking Undervalued Stocks ↗
Discover Innoviva (INVA), a value stock with strong fundamentals. It trades below intrinsic value, boasts a healthy balance sheet, and has promising growth prospects in biopharma. 
Via Chartmill
News headline image
Innoviva Inc (NASDAQ:INVA) Recognized as a "Decent Value" Stock with Strong Valuation and Growth Potential ↗
Innoviva (INVA) is a value stock with strong valuation metrics, solid financial health, and growth potential, making it an attractive pick for value investors. 
Via Chartmill
News headline image
Expert Outlook: Innoviva Through The Eyes Of 4 Analysts ↗
 
Via Benzinga
News headline image
This Arm Holdings Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Monday ↗
 
Via Benzinga
News headline image
Innoviva (INVA) Q2 Sales Jump 64% ↗
Via The Motley Fool
News headline image
This Cisco Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday ↗
 
Via Benzinga
News headline image
Rep. George Whitesides Has Sold Up to $5.18M Worth Of Innoviva Stock: Here's What You Should Know ↗
 
Via Benzinga
News headline image
Excelerate Energy, MediaAlpha And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
US Stock: Innoviva ↗
Innoviva Incorporated is a healthcare focused asset management company. The Company intends to participate in the development, commercialization, and financial management of bio-pharmaceuticals. 
Via Talk Markets
Topics Stocks / Equities
News headline image
INVA Stock Earnings: Innoviva Misses EPS, Beats Revenue for Q2 2024 ↗
INVA stock results show that Innoviva missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024. 
Via InvestorPlace
News headline image
The 3 Most Undervalued Under-$50 Stocks to Buy in July 2024 ↗
A full-throated bull market makes it tough to find undervalued stocks under $50, but these three could soon lead the charge higher. 
Via InvestorPlace
News headline image
3 Once-in-a-Lifetime Stock Picks Due for an Unprecedented Surge ↗
Discover three high-growth stock picks set for unprecedented surges in the metals, marine transportation, and pharmaceutical industries. 
Via InvestorPlace
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.